NASDAQ:AMBI AMBI (AMBI) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$4.09▼$4.4750-Day Range N/A52-Week Range N/AVolume4,781 shsAverage Volume28,052 shsMarket Capitalization$237.79 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsEarningsHeadlinesTrendsStock AnalysisCompetitorsEarningsHeadlinesTrends Get AMBI alerts: Email Address Ad Mode MobilePre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.Claim Exclusive 100% Bonus: $0.25/Share About AMBI Stock (NASDAQ:AMBI)Ambit Biosciences Corporation is a biopharmaceutical company. The Company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. The Company’s lead drug candidate, quizartinib, is in Phase IIb clinical development in patients with relapsed/refractory acute myeloid leukemia (AML). The Company’s second drug candidate in clinical development, AC410, is a potent, selective, orally-administered, small molecule inhibitor of Janus kinase 2 (JAK2) that has potential utility for the treatment of autoimmune and inflammatory diseases. The Company’s third program consists of two selective small molecule compounds, AC708 and AC855, which inhibit the colony-stimulating factor-1 receptor (CSF1R), a receptor tyrosine kinase.Read More Ad Mode MobilePre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.Claim Exclusive 100% Bonus: $0.25/Share AMBI Stock News HeadlinesSeptember 7 at 6:02 AM | msn.comAashu makes directorial and lead debut in 'Tommy'September 7 at 12:51 AM | theglobeandmail.comWhat we lose when words lose meaningSeptember 7, 2024 | Mode Mobile (Ad)Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.September 5 at 10:13 PM | uk.finance.yahoo.comSecret Whole Body Deodorant Helps You Smell Great Even in the AfterlifeSeptember 3, 2024 | uk.finance.yahoo.comDowny and Venus Williams Pair Up to Smash Tough Odor Out of LaundrySeptember 3, 2024 | msn.comTwo South Dakota Men Indicted For Distribution Of Fentanyl Resulting In DeathSeptember 3, 2024 | msn.comTwo South Dakota men charged with fentanyl deathSeptember 2, 2024 | msn.comTwo men charged with fentanyl deathSeptember 7, 2024 | Mode Mobile (Ad)Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.August 29, 2024 | uk.finance.yahoo.comP&G to Webcast Presentation From the Barclays Global Consumer Staples Conference, September 5August 29, 2024 | msn.comEverybody's Foraging! Experts Break Down Mindful BasicsAugust 29, 2024 | msn.comEXCLUSIVE: Chiyaan Vikram decodes climax of S Shankar's Anniyan and says, 'Inside my head...'August 17, 2024 | msn.comWhat Complexion Am I? Skin Complexion TypesAugust 16, 2024 | msn.comKuBe Gets New DirectorAugust 15, 2024 | msn.comHeartbreaking words from Kolkata doctor's father: 'She worked very hard, but ...'August 13, 2024 | msn.comBeauty, and the unfair search for a perfect brideAugust 12, 2024 | msn.comHelping cancer patients, one bead at a timeAugust 7, 2024 | msn.comA rainbow and a daddy - youngsters at a Nottinghamshire nursery share their ambitionsSee More Headlines Receive AMBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AMBI and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/09/2024Today9/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorIndustrial Products Industry Sanitary services Sub-IndustryN/A Current SymbolNASDAQ:AMBI CUSIPN/A CIK1131543 Webwww.hpxcorp.com Phone+1-858-3342100FaxN/AEmployees7,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio1.33 Current Ratio2.29 Quick Ratio2.21 Sales & Book Value Annual Sales$518.81 million Price / Sales0.46 Cash Flow$0.73 per share Price / Cash Flow5.87 Book Value$5.79 per share Price / Book0.74Miscellaneous Outstanding Shares55,430,000Free Float46,561,000Market Cap$237.79 million OptionableNot Optionable Beta0.64 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key CompetitorsPerma-Fix Environmental ServicesNASDAQ:PESICDT Environmental Technology InvestmentNASDAQ:CDTGLi-CycleNYSE:LICYClean HarborsNYSE:CLHStericycleNASDAQ:SRCLView All Competitors AMBI Stock Analysis - Frequently Asked Questions How were AMBI's earnings last quarter? AMBI (NASDAQ:AMBI) announced its quarterly earnings data on Friday, August, 9th. The biopharmaceutical company reported $0.24 earnings per share (EPS) for the quarter. The biopharmaceutical company earned $142.09 million during the quarter. What other stocks do shareholders of AMBI own? Based on aggregate information from My MarketBeat watchlists, some other companies that AMBI investors own include Alexion Pharmaceuticals (ALXN), Amarin (AMRN), Broadcom (BRCM), Cytokinetics (CYTK), Delta Air Lines (DAL), Fortress Biotech (FBIO) and FireEye (FEYE). This page (NASDAQ:AMBI) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredWhat is Nvidia’s New $1 Trillion SuperProject?Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AMBI Please log in to your account or sign up in order to add this asset to your watchlist. Share AMBI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.